Misfolded proteins destined for the cell surface are recognized and degraded by the ERAD [ER (endoplasmic reticulum) associated degradation] pathway. TS (temperature-sensitive) mutants at the permissive temperature escape ERAD and reach the cell surface. In this present paper, we examined a TS mutant of the CFTR [CF (cystic fibrosis) transmembrane conductance regulator], CFTR F508, and analysed its cell-surface trafficking after rescue [r F508 (rescued F508) CFTR]. We show that r F508 CFTR endocytosis is 6-fold more rapid (∼ 30 % per 2.5 min) than WT (wild-type, ∼ 5 % per 2.5 min) CFTR at 37
Misfolded proteins destined for the cell surface are recognized and degraded by the ERAD [ER (endoplasmic reticulum) associated degradation] pathway. TS (temperature-sensitive) mutants at the permissive temperature escape ERAD and reach the cell surface. In this present paper, we examined a TS mutant of the CFTR [CF (cystic fibrosis) transmembrane conductance regulator], CFTR F508, and analysed its cell-surface trafficking after rescue [r F508 (rescued F508) CFTR]. We show that r F508 CFTR endocytosis is 6-fold more rapid (∼ 30 % per 2.5 min) than WT (wild-type, ∼ 5 % per 2.5 min) CFTR at 37
• C in polarized airway epithelial cells (CFBE41o − ). We also investigated r F508 CFTR endocytosis under two further conditions: in culture at the permissive temperature (27 • C) and following treatment with pharmacological chaperones. At low temperature, r F508 CFTR endocytosis slowed to WT rates (20 % per 10 min), indicating that the cell-surface trafficking defect of r F508 CFTR is TS. Furthermore, r F508 CFTR is stabilized at the lower temperature; its half-life increases from < 2 h at 37
• C to > 8 h at 27
• C. Pharmacological chaperone treatment at 37
• C corrected the r F508 CFTR internalization defect, slowing endocytosis from ∼ 30 % per 2.5 min to ∼ 5 % per 2.5 min, and doubled F508 surface half-life from 2 to 4 h. These effects are F508 CFTR-specific, as pharmacological chaperones did not affect WT CFTR or transferrin receptor internalization rates. The results indicate that small molecular correctors may reproduce the effect of incubation at the permissive temperature, not only by rescuing F508 CFTR from ERAD, but also by enhancing its cell-surface stability.
INTRODUCTION
The CFTR [CF (cystic fibrosis) transmembrane conductance regulator] is a cAMP-activated chloride channel expressed in a variety of tissues [1] [2] [3] [4] . CFTR functions in the apical membrane of polarized epithelial cells and undergoes endocytosis via clathrin-coated vesicles [5] [6] [7] [8] [9] [10] [11] . Mutations in the CFTR gene lead to CF, the most common hereditary lethal disease among Caucasians [12, 13] . There are more than 1500 mutations listed in the CFTR mutation database (http://www.genet.sickkids. on.ca/cftr), but a 3 bp deletion resulting in loss of a phenylalanine residue at position 508 ( F508) is the most prevalent diseasecausing mutation.
F508 CFTR is a well-known example of a clinically relevant TS (temperature-sensitive) processing mutant. At 37
• C, the restrictive temperature, the F508 CFTR protein is rapidly degraded by ERAD [ER (endoplasmic reticulum) associated degradation], preventing F508 CFTR expression at the cell surface and resulting in the CF phenotype [14] [15] [16] . At 27 • C, the permissive temperature, some of the F508 CFTR protein escapes ERAD and is delivered to the cell membrane, where it is called r F508 (rescued F508) CFTR. Because r F508 CFTR partially retains its chloride channel activity [17] , several methods have been introduced to promote F508 CFTR escape from ERAD and deliver it to the cell membrane [18] [19] [20] [21] [22] [23] [24] , but to date, the most efficient method for the rescue of F508 CFTR is permissive temperature cell culture [25] . Although first observed 15 years ago, it remains unclear how culture at 27
• C facilitates F508 CFTR escape from ER quality control. It is well established, however, that returning cells to the restrictive temperature after low temperature rescue results in rapid internalization and degradation of r F508 CFTR [26, 27] . It is not known whether r F508 CFTR displays the same cell-surface instability, or how function of r F508 CFTR is affected, if left at the permissive temperature.
In addition to low-temperature culture, chemical compounds such as glycerol [28] , DMSO [29] and organic solutes [24] have also been shown to facilitate F508 CFTR escape from ERAD. These compounds exert their effects by enhancing the efficiency of F508 CFTR folding or by increasing differentiation and polarity of the host cell [29] . Recently, a handful of small molecular correctors were identified by high-throughput screening based on their ability to promote r F508 CFTR expression [20, 22, 30, 31] . In most cases, the mechanism by which these compounds facilitate ERAD escape is not known. Furthermore, their effects at the cell surface have not been tested.
Although the effects of low temperature culture on F508 CFTR folding in the ER has been studied for years, it is not Abbreviations used: BHK, baby-hamster kidney; CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; ER, endoplasmic reticulum; ERAD, ER-associated degradation; DF, indicates cell line expressing F508 CFTR; FBS, fetal bovine serum; HRP, horseradish peroxidase; I sc , shortcircuit current; MEM, minimal essential medium; NS, not significant; r F508, rescued F508; R t , transepithelial resistance; TR, transferrin receptor; TS, temperature-sensitive; WT, wild-type. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email jcollawn@uab.edu).
known whether the surface defects exhibited by r F508 CFTR are also TS, and therefore possibly related to the ER folding defect. Additionally, it has not been determined whether treatment of r F508 CFTR with chemical compounds known to promote rescue can affect F508 CFTR cell-surface properties, such as surface stability. Answers to these questions are essential to understand the altered trafficking, decreased stability and compromised function of the r F508 CFTR protein.
In this present study, we provide more detailed information on the effects of permissive temperature culture and of two small molecule correctors on r F508 CFTR cell-surface trafficking. We used two different CFTR-expressing model cell lines, HeLa and CFBE41o − cells, in order to identify cell-type-and polarization-specific differences in the cell-surface trafficking of WT (wild-type) CFTR and r F508 CFTR, and to determine whether methods known to facilitate F508 CFTR exit from the ER also stabilize r F508 CFTR at the cell surface.
EXPERIMENTAL

Cell lines and cell culture
Cells were maintained in a 37
• C humidified incubator in 5 % CO 2 . HeLa F (where F indicates a cell line expressing F508 CFTR), HeLaWT, CFBE41o
− F and CFBE41o − WT cell lines were developed and cultured as described previously [26] . HeLa cells were grown in Eagle's modification of MEM (minimal essential medium; Invitrogen) supplemented with 10 % (v/v) FBS (fetal bovine serum). Calu-3 cells were obtained from A.T.C.C. and were maintained in Eagle's modification of MEM supplemented with 10 % (v/v) FBS, 2 mM glutamine, 1 mM pyruvate and 0.1 mM non-essential amino acids. CFBE41o − F and CFBE41o − WT cells were seeded on to 12 mm diameter Transwell filters (Costar, Corning). Under these conditions, the cells formed polarized monolayers with transepithelial resistances of > 1000 /cm 2 , as measured by a Millicell electrical resistance system (Millipore).
Small molecular correctors (pharmacological chaperones)
Small molecular correctors were provided by Cystic Fibrosis Foundation Therapeutics (Bethesda, MD, U.S.A.). Compounds tested were CFcor-325 (VRT-325, 4-cyclohexyloxy-2-{1[4-(4-methoxy-benzensulfonyl)-piperazin-1-yl]-ethyl}-quinazoline) [20, 32] and Corr-4a ({2-(5-chloro-2-methoxy-phenylamino)-4 -methyl- [4, 5 ] -bithiazolyl-2 -yl}-phenyl-methanone) [22] . Both compounds were used at a 10 mM stock concentration in DMSO and a 10 µM working concentration in OPTIMEM medium (Invitrogen) supplemented with 2 % (v/v) FBS. The presence of the vehicle (0.1 % DMSO) in the medium did not mediate ER escape of F508 CFTR in control samples, or facilitate changes in internalization. In all experiments, control samples contained the DMSO vehicle.
Immunoprecipitation
Cells were lysed in RIPA buffer [1 % Nonidet P40, 0.5 % sodium deoxycholate, 150 mM NaCl and 50 mM Tris/HCl (pH 8.0)] containing Complete mini protease inhibitor (Roche). CFTR was immunoprecipitated using 1 µg/ml (final concentration) mouse monoclonal anti-CFTR C-terminal antibody (24-1, A.T.C.C. number HB-11947) and 35 µl of Protein A-agarose (Roche) [8] . TR (transferrin receptor) was immunoprecipitated using 1 µg/ml (final concentration) mouse anti-TR (B3/25; Roche) and 35 µl Protein A-agarose [33] . Immunoprecipitations were carried out for 2 h at 4
• C.
Internalization assays
CFTR internalization assays were performed as described previously [8, 9] . Briefly, surface carbohydrate groups on the cells were oxidized with sodium periodate (NaIO 4 , 10mM), washed on ice with Mg 2+ -and Ca 2+ -supplemented (0.5 mM MgCl 2 and 0.9 mM CaCl 2 ) PBS buffer and warmed to 37
• C or 27
• C for 2.5 or 10 min. Oxidized surface carbohydrate groups remaining on the cell surface after a warm-up period were labelled with biotin-LC-hydrazide (1 mg/ml; Pierce), followed by cell lysis in RIPA buffer. CFTR was then immunoprecipitated as described above. CFTR internalization was identified as the percentage loss of biotinylated CFTR during the warm-up period compared with the control samples (no warm-up period).
CFTR cell-surface half-life measurements
Cells were metabolically labelled [8] and biotinylated as described previously [9] . Initial (0 time point) samples were immediately lysed in RIPA buffer, and the rest of the samples were transferred into to a 37
• C incubator for 2, 4 and 8 h. At each time point, cells were lysed in RIPA buffer, CFTR was immunoprecipitated and analysed by SDS/PAGE (6 % gels) and Western blotting (see below), and autoradiography was performed following the manufacturer's instructions (PhosphorImager; Amersham Biosciences). Half-lives of the proteins were calculated as described previously [8, 34] .
Metabolic pulse-chase experiments
For experiments at 37
• C, cells were metabolically labelled as described previously [8] . For metabolic labelling during permissive temperature (27 • C) culture, cells were transferred to 27
• C and the medium replaced with cysteine-and methionine-free MEM (Specialty Media, Phillipsburg, NJ, U.S.A.) for 1 h. Cells were subsequently incubated with 300 µCi/ml [ 35 S]methionine/ cysteine (EasyTag TM ; PerkinElmer) for 18 h at 27 • C. This extended metabolic labelling pulse was necessary to produce a labelled CFTR signal at 27
• C that formed sufficient quantities of mature, glycosylated CFTR (C band) to follow during the chase period. On completion of labelling, the medium was replaced with complete medium without radioisotopes and cells were cultured at either 37
• C for the time points indicated.
Western Blot
Total and biotinylated CFTR or TR were detected as described previously [8] . Briefly, CFTR and TR were immunoprecipitated and analysed by SDS/PAGE (6% gels) and Western blotting. Membranes were blocked overnight in 3 % (w/v) BSA and 0.5 % Tween 20 in PBS. All antibodies were incubated for 1 h at 25 • C. Total CFTR was detected with polyclonal anti-[CFTR NBD (nucleotide binding domain)2] antibody (1:5000 dilution, H-182; Santa Cruz Biotechnology). Total TR was detected with a polyclonal anti-(TR external domain) antibody (1:5000 dilution; MorphoSys, Raleigh, NC, U.S.A.). Biotinylated CFTR and TR were detected with HRP (horseradish peroxidase)-conjugated avidin (1:5000 dilution; Sigma). Chemiluminescence was induced with high-sensitivity Immobilon Western substrate (Millipore). The membranes were exposed for different time periods (up to 3 min) and a linear range for a standard set of diluted samples was calibrated. Western blots were analysed and densities measured using ImageJ (National Institutes of Health), ScionImage (National Institutes of Health), or IPLab (BD Biosciences) software. Results are means (n 3).
Ussing chamber analyses
Measurements of I sc (short-circuit current) and R t (transepithelial resistance) were performed as described previously [35] . Briefly, filters containing monolayers of either CFBE41o − F or CFBE41o
− WT cells were mounted in Ussing chambers (Jim's Instruments, Iowa City, IA, U.S.A.) and bathed on both sides with solutions containing 120 mM NaCl, 25 mM NaHCO 3 , 3.3 mM KH 2 PO 4 , 0.83 mM K 2 HPO 4 , 1.2 mM CaCl 2 , 1.2 mM MgCl 2 , 10 mM Hepes (sodium-free), 10 mM mannitol (apical compartment) and 10 mM glucose (basolateral compartment). Osmolality of all solutions, as measured by a freezing depression osmometer (Wescor, Logan, UT, U.S.A.), was between 290 and 300 mOsm/kg of water. The bath solutions were stirred vigorously by continuous bubbling with 95 % O 2 and 5 % CO 2 at 37
• C (pH 7.4). Monolayers were short-circuited to 0 mV, and I sc (µA/cm 2 ) was measured with an epithelial voltage clamp (VCC-600; Physiologic Instruments, San Diego, CA, U.S.A.). A 10 mV pulse of 1 s duration was imposed every 10 s to monitor R t , which was calculated using Ohm's law. Data were collected using the Acquire and Analyse program (version 1.45; Physiologic Instruments). Results are I sc forskolin (response to forskolin) and I sc glybenclamide (response to glybenclamide). During Ussing chamber analysis, the temperatures (27
• C or 37
• C) were maintained by using a temperature-controlled water bath for at least 30 min before analysis. Following establishment of steadystate values of I sc and R t , forskolin (10 µM) and/or the indicated inhibitors were added to the apical compartments, and I sc and R t were measured continuously until new steady-state values were reached.
Statistical analysis
Results are means + − S.D. and statistical significances were calculated by using the two-tailed Student's t test.
RESULTS
F508 CFTR rescue by permissive temperature in HeLa F cells
In order to study the cell-surface trafficking of r F508 CFTR, we first established whether permissive temperature culture of HeLa F cells could generate sufficient amounts of fully glycosylated F508 CFTR at the cell surface in order to measure endocytosis rates. Following culture at 27
• C for 48 h, CFTR was immunoprecipitated from whole-cell lysates and analysed for the presence of mature, glycosylated band C (r F508 CFTR). The results in Figure 1 (A) demonstrate that a significant amount of fully glycosylated CFTR is formed during 27
• C culture. To confirm that the fully glycosylated r F508 CFTR was expressed at the cell surface, cells were surface biotinylated using biotin-LC-hydrazide [9] . Biotinylated CFTR was detected in HeLa F cells after 27
• C culture, but not in cells maintained at 37
• C ( Figure 1A ). Control cells expressing WT CFTR served as a comparison in order to illustrate the level of F508 CFTR rescue.
To determine the stability of r F508 CFTR after permissive temperature rescue, WT CFTR-or r F508 CFTR-expressing HeLa cells were raised to the restrictive temperature and the protein half-lives of WT CFTR and r F508 CFTR were determined by metabolic pulse-chase analysis. For these experiments, cells were cultured at 27
• C for 24 h and metabolically labelled with [
35 S]methionine for an additional 18 h at 27
• C (see the Experimental section). The cells were then returned to 37
• C, and the labelled proteins were chased for the time periods specified. The results indicate that the half-life of WT CFTR is 12 + − 1.5 h, whereas the half-life of r F508 CFTR is 4 + − 1 h ( Figure 1B ). The r F508 CFTR protein half-life is much shorter than that of WT CFTR (P < 0.001), and these results are in agreement with previously published experiments performed in BHK (baby-hamster kidney) and CHO (Chinese-hamster ovary) cells [7, 36] .
Extended half-life of r F508 CFTR at the permissive temperature in HeLa F cells
Next, we tested whether extended culture at the permissive temperature would affect the half-lives of WT CFTR and r F508 CFTR in HeLa cells. We followed the protocol described above (see the Experimental section), but instead of transferring the cells to 37
• C after metabolic labelling, they were incubated at 27
• C for the time periods indicated. The results show that at 27
• C, the half-lives of WT CFTR and r F508 CFTR were 60 + − 11 h and 63 + − 9 h respectively ( Figure 1C) , demonstrating that the instability of r F508 CFTR compared with WT CFTR which was observed at the restrictive temperature is not apparent at the permissive temperature; in other words, the r F508 CFTR halflife defect is a TS defect.
We next sought to determine why r F508 CFTR has a short half-life at the restrictive temperature by examining the internalization properties of WT CFTR and r F508 CFTR in HeLa cells and epithelial cells (CFBE41o − and Calu-3) under both non-polarized and polarized conditions. These experiments served to test cell-type-and polarization-specific differences in the trafficking of the two proteins.
r F508 CFTR endocytosis is accelerated in airway epithelial cells
To determine the cell-surface stability of WT CFTR and r F508 CFTR in HeLa cells at 37
• C, we measured their internalization rates using a two-step biotinylation protocol [8] . To measure CFTR endocytosis rates, we oxidized the surface carbohydrate groups of cell surface glycoproteins at the initial (zero) time point (see the Experimental section) and then allowed the proteins to be internalized for 2.5 min, at which time the oxidized glycoproteins remaining at the cell surface were labelled with biotin. An internalization time of 2.5 min was chosen for all assays conducted at 37
• C because, at this temperature, previous internalization time courses in multiple cell lines indicated that periodate-oxidized CFTR modified at the initial time point did not recycle back to the cell surface (results not shown). Since the biotin-LC-hydrazide is membrane impermeable, the only biotin-accessible CFTR is what remains on the cell surface during the warm-up period (see the Experimental section). Therefore changes in the surface pool of CFTR after a 2.5 min warm-up period were reflected in a loss of 'biotinylatable' CFTR, and this loss corresponds to the amount of CFTR that had been internalized from the cell surface.
Following biotin labelling, cells were lysed and total CFTR was immunoprecipitated as described above. At each time point, biotinylated CFTR was detected by Western blot with HRPconjugated avidin. With this protocol, biotin labelling of band B CFTR is not observed unless cells are first permeabilized [9] , suggesting that under non-permeabilizing conditions such as those presented herein, this biotinylation method used does not label intracellular proteins. The results of these experiments indicate that both WT CFTR and r F508 CFTR endocytosis rates are rapid, with 25 + − 5 % and 27 + − 5 % of the surface pool internalized in 2.5 min respectively (Figure 2A ). This result is consistent with a previous comparison of WT CFTR and r F508 CFTR internalization rates in BHK cells [27] .
Since in vivo CFTR is expressed on the apical surface in epithelial cells, we next compared the surface stability of WT CFTR and r F508 CFTR in both polarized and non-polarized human airway epithelial cells at 37
• C. In CFBE41o − WT cells grown on plastic dishes (non-polarized cells), CFTR endocytosis slowed to 14 + − 4 % of the surface pool internalized in 2.5 min (P = 0.02 compared with HeLaWT). In contrast, 29 + − 5 % of r F508 CFTR was internalized during the same time period in CFBE41o − F ( Figure 2B ), a rate similar to that seen in HeLa F cells [P = NS (not significant)]. Furthermore, the difference between WT CFTR and r F508 CFTR internalization rates was more pronounced when the cells were grown as polarized monolayers. In polarized cells, WT CFTR internalization dropped significantly to 3.2 + − 2 % per 2.5 min (P < 0.0001 compared with HeLaWT), whereas r F508 CFTR internalization remained at 30 + − 3 % per 2.5 min. As a further control, we measured WT CFTR internalization in polarized Calu-3 cells with similar results (5 + − 1 % per 2.5 min; P = NS), indicating that the surface pool of WT CFTR is very stable in polarized epithelia ( Figure 2C ), whereas r F508 CFTR is not stable. Because it was clear that WT CFTR trafficking did not appear to be faithfully represented in HeLa cells, and our goal was to identify the defect in r F508 CFTR compared with the control WT CFTR protein, we focused our efforts on analysing the r F508 CFTR trafficking defect in human airway epithelial cells.
Shortened cell-surface half-life of r F508 CFTR in CFBE41o
− F cells
Because polarization affected WT CFTR but not r F508 CFTR internalization, we then tested the cell-surface half-lives of both Representative gels are shown of WT CFTR (CFBE WT, top panels) and r F508 CFTR (CFBE F508, middle panels) half-life measurements performed at 37 • C under non-polarized and polarized conditions. Half-lives were calculated using densitometry followed by analysis as described previously [34] , and the results are shown in the bottom panel (n = 4).
WT CFTR and r F508 CFTR in CFBE41o
− cells using a cellsurface biotinylation-based assay (Figure 3) . The results indicate that the surface half-life of biotinylated WT CFTR was 8.5 + − 1 h in non-polarized cells (Figure 3 , top left-hand panel) and 8.3 + − 0.3 h in polarized cells (P = NS, Figure 3 , top right-hand panel), demonstrating that the stability of the WT CFTR protein was not affected by cell polarization. Examination of r F508 CFTR indicated that the surface half-life of the rescued protein was very short (less than 2 h) under both non-polarized and polarized conditions (1.8 + − 0.1 compared with 2.0 + − 0.2 h respectively; P = NS, Figure 3 , middle panels). Thus r F508 CFTR surface stability is decreased compared with WT CFTR, and polarization did not affect the surface stability of either protein (Figure 3 , bottom panels).
Permissive temperature culture stabilizes r F508 CFTR in polarized epithelial cells
Since the r F508 CFTR trafficking defect in epithelial cells is the result of enhanced endocytosis, we tested whether permissive temperature culture could correct this defect. To answer this question, we compared the effects of 27
• C treatment on WT CFTR and r F508 CFTR cell-surface trafficking in polarized CFBE41o
− cells using cell-surface half-life and internalization experiments. The results show that both WT CFTR and r F508 CFTR are extremely stable at the cell surface at 27
• C, with cellsurface half-lives much greater than 8 h (Figure 4 , top panels). Because CFTR levels were not monitored beyond 8 h, we cannot calculate to what extent permissive temperature culture stabilized WT CFTR or r F508 CFTR. However, since WT CFTR and r F508 CFTR surface half-life measurements were similar at 27
• C, these results reveal that 27
• C treatment eliminated the drastic difference in surface half-life between WT CFTR and r F508 CFTR observed at 37
• C. Measurement of WT CFTR
Figure 4 Surface stability of r F508 CFTR at 27 • C in airway epithelial cells
Cell surface stability (top panels) and internalization rates (middle panels) of CFTR were measured at 27 • C (see Experimental section). In polarized CFBE41o − cells, both WT CFTR and r F508 CFTR are extremely stable at 27 • C. There was no detectable decrease in biotinylated Band C CFTR during the 8 h chase. Representative gels from CFBE41o − WT and CFBE41o − F ( F508) are shown (top panels). For internalization rates, total and cell surface CFTR were detected. Representative gels are shown (middle panels). Internalization rates are plotted as the percentage decrease in density of Band C CFTR at 10 min (bottom panel; n = 4). Biot., biotinylated CFTR.
and r F508 CFTR internalization rates at 27
• C revealed a dramatic decrease in both cell lines. In fact, CFTR internalization was not measurable after the 2.5 min warm-up period. After a 10 min warm-up period, WT CFTR and r F508 CFTR internalization rates were 20 + − 3 % per 10 min (P = 0.05) and 22 + − 4 % per 10 min (P = 0.0004) respectively (Figure 4 , middle and bottom panels), which indicated that 27
• C treatment eliminated the difference in internalization rates between WT CFTR and r F508 CFTR. Importantly, the results of these studies indicate that both the short surface half-life and the rapid internalization rate of r F508 CFTR are TS defects.
Permissive temperature culture corrects the functional defect associated with r F508 CFTR
In addition to the trafficking defect, r F508 CFTR fails to respond to cAMP after forskolin stimulation in CFBE41o − F cells [26] . Since we observed that permissive temperature culture corrects the endocytosis defect in r F508 CFTR and restores the protein half-life to levels equivalent to WT CFTR, we then tested whether it might also correct the functional defect [26] . In these experiments, polarized CFTR-expressing CFBE41o − F monolayers were cultured at 27
• C for 48 h to facilitate r F508 CFTR expression on the cell surface. These monolayers were then mounted in Ussing chambers, where cAMP-activated I sc was measured at either 37
• C or 27 • C. Forskolin (10 µM) was added to the apical compartment to enhance intracellular cAMP levels and activate I sc . When the current reached a maximum and stabilized, glybenclamide was added at increasing concentrations to block 
Polarized CFBE41o
− WT and CFBE41o − F ( F508) monolayers were cultured at 27 • C for 48 h. Cells were mounted in Ussing chambers and temperature-equilibrated (37 • C or 27 • C as indicated) for 30 min, followed by measurement of baseline steady state I sc and R t values. Forskolin (FSK, 10 µM) was added to the apical chambers, and I sc and R t values were monitored until a new baseline was obtained. The indicated concentrations of glybenclamide (GLYB) were then added apically, and I sc and R t values were monitored. Representative traces (top and middle panels) are shown. Results are I sc (µA/cm 2 ) of FSK (which represents a positive current following forskolin activation) or of GLYB, which represents a negative current following administration of glybenclamide to block channel activity (bottom panels; n 5). F508 CFTR-expressing monolayers exhibited significantly blunted responses to forskolin and glybenclamide compared with WT CFTR-expressing monolayers at 37 • C (bottom panels). These responses were significantly enhanced when monolayers were maintained at the permissive temperature (27 • C, * P < 0.005; + P < 0.01), so that there were no significant differences between WT CFTR and r F508 CFTR responses at this temperature (bottom panels). For each condition, the number of experimental repeats is indicated in parentheses.
I sc . In some experiments, a CFTR-specific inhibitor was used to block currents [23] , as described previously [35] . Forskolin was used consistently to activate I sc because we found that, in both WT CFTR-and F508 CFTR-expressing cells, it was sufficient to stimulate cAMP-mediated chloride currents. A cocktail designed to maximally stimulate cAMP responses [forskolin, IBMX (3-isobutyl-1-methylxanthine) and bromoadenosine-cAMP] did not increase the current beyond the forskolin-induced current. Likewise, glybenclamide was used consistently because the CFTR-specific inhibitor did not further inhibit the currents, indicating that glybenclamide provided maximal CFTR channel inhibition (results not shown). The magnitude of the resulting I sc was compared with parallel CFBE41o − WT controls (see the Experimental section). The results show that at 37
• C, cells expressing WT CFTR channels produce an anion current that is readily stimulated by forskolin and can be inhibited completely by glybenclamide ( Figure 5 , top left-hand panel), whereas cells expressing r F508 CFTR exhibit very weak responses to both treatments ( Figure 5 , middle left-hand panel), in agreement with our previous findings [26] . When the temperature is maintained at 27
• C, however, r F508 CFTR-expressing cells exhibit an anion current similar to cells expressing WT CFTR ( Figure 5 , top and middle right-hand panels). Direct channel stimulation by 50 µM genistein further enhanced the r F508 CFTR current at 27
• C (results not shown), in agreement with a previous observation that at 37 • C, r F508 CFTR produced a current in response to genistein [29] . This restoration of the functional defect suggests that the loss of cAMP response has been regained at 27
• C. In consideration with the previous studies, these experiments reveal that both the surface trafficking and functional activity defects of r F508 CFTR are TS.
Pharmacological chaperones correct the internalization defect and increase the surface stability of r F508 CFTR
As shown above, maintenance of the TS F508 protein at the permissive temperature corrects multiple trafficking and functional defects, in that 27
• C treatment not only rescues F508 CFTR from ERAD, but also stabilizes the endocytosis and surface stability defects as long as cells are maintained at 27
• C. On the basis of these results, we investigated whether two pharmacological chaperones which facilitate F508 CFTR exit from the ER, a quinazoline compound (CFcor-325) and a bisaminomethylbithiazole compound (Corr-4a) [20, 31] , have any effect on r F508 CFTR or WT CFTR cell-surface trafficking at 37
• C. First, we studied the effect of the compounds on WT CFTR and r F508 CFTR endocytosis in CFBE41o
− cells. For these experiments, CFBE41o
− WT or − F cells were cultured for 48 h Internalization assays for WT CFTR (WT) and r F508 CFTR ( F508) were performed at 37 • C in CFBE41o − F and CFBE41o − WT cells following low temperature rescue in the presence or absence of CFcor-325 or Corr-4a. Representative gels (top panels) and the percentage of CFTR internalized for each corrector is shown (middle panels; n = 4). The percentage of TR internalized, measured under identical conditions, is also shown (bottom panels). WT CFTR and TR internalization rates were tested as controls and ∼ 5 % of WT CFTR and ∼ 30 % of rescued F508 CFTR was internalized in 2.5 min in untreated cells. Both CFcor-325 and Corr-4a treatment significantly decreased r F508 CFTR internalization in CFBE41o − F cells (n = 4; P < 0.05). No changes in WT CFTR and TR internalization rates were measured.
at 27
• C, followed by a 1 h pre-treatment with 10 µM CFcor-325, Corr-4a, or a vehicle control (DMSO) at 37
• C. Internalization assays were then performed at 37
• C. The results indicated that both CFcor-325 and Corr-4a decreased the internalization rate of r F508 CFTR from 30 % to ∼ 5 % and ∼ 1 % respectively (P < 0.005, Figure 6 , top and middle panels). Interestingly, the compounds had no effect on WT CFTR endocytosis or TR endocytosis from the apical surface ( Figure 6 , bottom panels), suggesting that the effect was specific for r F508 CFTR.
Pharmacological chaperones extend the cell-surface half-life of r F508 CFTR Next, we monitored the effects of CFcor-325 or Corr-4a on the cell-surface half-life of WT CFTR and r F508 CFTR. For these experiments, CFBE41o
− WT or − F cells were cultured for 48 h at 27
• C, followed by treatment with 10 µM CFcor-325, Corr-4a or a vehicle control (DMSO) at 37
• C. CFTR cell-surface half-lives were then evaluated in the presence of correctors or vehicle using the surface biotinylation-based assay. The results indicated that treatment with either small molecule corrector stabilized r F508 CFTR compared with untreated controls (Figure 7) . CFcor-325 extended the half-life of r F508 CFTR from 2.5 + − 0.4 h to 4.6 + − 0.9 h (P = 0.004), and Corr-4a extended the half-life from 2.6 + − 0.6 h to 4.5 + − 1.2 h (P = 0.03), indicating that both compounds stabilized the half-life of r F508 CFTR. Significantly, neither compound affected the half-lives of WT CFTR nor TR (Figure 7 , bottom panels), suggesting the effects observed are specific for r F508 CFTR.
DISCUSSION
The fate of r F508 CFTR at the cell surface after low temperature rescue is one of the first examples of how the cellular quality-control mechanisms operate at the plasma membrane and/or early endosomes [27] . Although culture at the permissive temperature allows some of the TS F508 CFTR protein to escape from ERAD, this maturely glycosylated r F508 CFTR is rapidly degraded once the temperature is raised to the restrict- 
Polarized CFBE41o
− F ( F508) and CFBE41o − WT (WT) cells were cultured at 27 • C for 48 h, returned to 37 • C, and treated with CFcor-325 or Corr-4a for 8 h. Cell-surface CFTR half-lives were measured following cell-surface biotinylation (see Experimental section). Representative gels (top panels) and the mean CFTR half-life for each pharmacological agent and untreated control (middle panels; n = 4) are shown. The TR half-life was also measured in the presence or absence of correctors as an additional control (bottom panels; n = 4).
ive temperature, 37
• C. The goal of this study was to follow the cell surface fate of r F508 CFTR at the permissive and restrictive temperatures, 27
• C and 37
• C, and compare the results with the WT CFTR protein. Since CFTR is normally expressed in epithelial cells, we also examined the fate of both proteins in polarized epithelia to determine whether any epithelial-specific differences exist between WT CFTR and r F508 CFTR surface trafficking. Additionally, we performed functional studies to measure transepithelial chloride currents in response to physiological stimuli, such as cAMP. Finally, on the observation that permissive temperature treatment stabilizes and functionally corrects r F508 CFTR at the cell surface, we tested whether pharmacological chaperones that permit escape from ERAD stabilize the r F508 CFTR surface pool.
A number of studies have shown that culturing cells at 27
• C is an efficient method of facilitating F508 CFTR delivery to the cell surface [7, 10, [18] [19] [20] 22, [24] [25] [26] [27] 31, 36] . However, the fate of the low temperature-cultured r F508 CFTR at the cell surface has only been followed at 37
• C [10, 26, 27] . Here, we show that when the cells are kept at 27
• C, the stability of r F508 CFTR is enhanced, and the differences between WT CFTR and r F508 CFTR trafficking and half-life that are seen at 37
• C disappear. One potential explanation for this observation is that protein degradation slows down at the permissive temperature, resulting in accumulation of both the WT CFTR and F508 CFTR. This hypothesis is supported by the finding that ubiquitination of r F508 CFTR is inhibited at 28
• C [27] . However, another possibility is that at 27
• C, F508 CFTR folds properly and remains in a properly-folded state, resulting not only in exit from the ER, but also in a more stable surface phenotype at this temperature. When cells are returned to 37
• C, the conformation of r F508 CFTR reverts to a misfolded stage, as proposed previously [36] . In this misfolded conformation, proteins are more likely to be accessible to ubiquitination and subsequent degradation by cell-surface-associated mechanisms.
The endocytosis defect of r F508 CFTR is eliminated at 27
• C, but our results indicate that endocytosis still occurs, albeit more slowly. In a number of cell types, temperatures between 16
• C and 22
• C block degradation of endocytosed proteins by preventing their transport to lysosomes [37] [38] [39] . F508 CFTR has been shown to accumulate in endocytic-like structures similar to the WT CFTR protein when the cells were shifted to 16
• C [7] , consistent with the idea that the early part of the endocytic pathway still operates at this temperature, but delivery to the later stages is blocked. It remains unclear whether transport to the lysosome, lysosomal processing or the initial steps of ubiquitindependent endocytosis are still functional at 27
• C, but it is clear from our results here that internalization of r F508 CFTR is dramatically slowed down to WT CFTR levels at 27
• C, which is consistent with the latter possibility. Further support for this idea comes from proteasomal inhibition studies using lactacystin in BHK cells expressing r F508 CFTR [7] . In these studies, lactacystin treatment dramatically stabilized the surface pool of r F508 CFTR [7] , consistent with the idea that the free ubiquitin pool is limited during proteasomal inhibition.
One important result from our study is that the surface defect of r F508 CFTR is due to an enhanced endocytosis rate compared with WT CFTR. Interestingly, we have also shown here that this defect is only present in polarized epithelial cells, such as CFBE41o
− cells, and not in HeLa cells. Our results demonstrate that WT CFTR endocytosis is dependent both on cellular background and on polarization. In non-polarized HeLa cells, more than 30 % of WT CFTR internalizes within 2.5 min.
In CFBE41o
− WT and Calu-3 cells grown on plastic dishes (nonpolarized cells), CFTR internalization slows down to ∼ 15 %. When the cells are grown on permeable supports (polarized), CFTR internalization is only 2-5 % in 2.5 min.
It is tempting to speculate that WT CFTR internalization rates are so low in polarized epithelia because the majority of WT CFTR is anchored to the cytoskeleton and does not participate in the internalization process. This notion is consistent with the results of Haggie et al. [40] , in which single-particle tracking was used to demonstrate that CFTR is coupled to the actin cytoskeleton via EBP50 (ezrin/radixin/moesin-binding phosphoprotein-50)/ezrin and immobilized at the plasma membrane.
The difference we observed in WT CFTR internalization rates in polarized epithelia differs from our results in HeLa cells and from the work of Lukacs and co-workers in BHK cells [27] . One explanation for these discordant results is that in non-polarized cells, the cell membrane and the cytoskeleton are less organized compared with polarized cells, resulting in inefficient tethering of WT CFTR and an increased mobile pool available for endocytosis.
Importantly, we observed that the trafficking of r F508 CFTR did not follow the same kinetics as WT CFTR in polarized epithelial cells, at least at 37
• C. At this temperature, regardless of cell line or polarization, r F508 CFTR endocytosis rates remain consistently high (∼ 30 % in 2.5 min). One possible explanation for this observation is that, in contrast to our model for WT CFTR, the majority of r F508 CFTR is not tethered properly to the cytoskeleton, resulting in a more mobile surface pool. This inefficient cytoskeletal tethering could result from the inability of the mutant protein to interact with one or more of the cytosolic factors responsible for stabilization of the WT CFTR protein. The idea that r F508 CFTR is not in a large macromolecular complex is supported by the observation that r F508 CFTR is poorly responsive to cAMP-mediated stimuli in CFBE41o
− F cells at 37
• C [26] , suggesting that r F508 CFTR has lost the association with the previously identified apical signalling complex [7, 26, 41] . Alternatively, it is possible that, after rescue from ERAD at the permissive temperature, r F508 CFTR reverts to a misfolded state when cells are returned to the restrictive temperature. The resulting conformational alterations in the protein may enhance its ability to interact with the clathrin-based endocytic machinery and/or cell-surfaceassociated ubiquitination machinery. The consequence is that r F508 CFTR may be endocytosed and degraded in the lysosome more actively than the WT CFTR protein at 37
• C. Because improved surface half-life does not necessarily translate to improved channel activity, it is essential to note that the biochemical rescue mediated by permissive temperature culture is accompanied by a functional correction. We showed that after permissive temperature rescue, continued culture at 27
• C results in r F508 CFTR channels which are functionally similar to WT CFTR channels in their ability to respond to physiological stimuli such as forskolin. This functional correction also supports the idea that at the permissive temperature, the rescued protein is associated with the functional complex [26] that allows activation by cAMP. The idea that the channel activity is TS is further supported by a recent report on F508 CFTR with two altered RXR motifs that demonstrated that the single channel activity of r F508 CFTR decreased as the temperature was increased from 30
• C to 37 • C [42] . Since extended culture at the permissive temperature slowed the endocytosis rates of r F508 CFTR to WT CFTR levels in addition to mediating its escape from ERAD, an obvious question was whether chemical correctors that facilitate F508 CFTR exit from the ER would also provide r F508 CFTR cell-surface stability at 37
• C. The results illustrated that two small molecules known to rescue F508 CFTR from ERAD, CFcor-325 and Corr-4a, also stabilized the mutant protein at the cell surface. Importantly, these compounds had no effect on endocytosis or the protein half-life of two other cell-surface molecules, WT CFTR and TR, suggesting that the effects are r F508 CFTR-specific. Further support for the idea that the compounds are specific was provided by a recent report by Clarke and co-workers demonstrating that these compounds interact directly with CFTR [43] .
A significant result of this study is that both compounds corrected the r F508 CFTR internalization defect to WT CFTR rates. Despite this effect, although the surface half-life of the rescued protein increased with these compounds, the corrected half-life remained significantly shorter than WT CFTR. This result indicates that correcting the internalization defect of the r F508 CFTR protein may not be sufficient for optimal stabilization, and supports previous findings that impaired recycling is a critical component in the compromised surface stability of r F508 CFTR [27] .
In summary, in polarized epithelial cells, permissive temperature culture of a TS mutant, F508 CFTR, not only rescues it from ERAD, but also stabilizes it at the cell surface and restores its cAMP responsiveness, suggesting that both the stability and the functional defects at the cell surface are TS, not just the maturation defect. Two pharmacological chaperones, CFcor-325 and Corr4a, mediate an effect similar to permissive temperature treatment, but the r F508 CFTR correction of cell-surface half-life is only partial. Our results indicate that permissive temperature culture of a clinically-relevant TS ER processing mutant can facilitate correction of both cell-surface trafficking and functional defects, and offer hope that the treatments that enhance the release of misfolded proteins from the ER may also benefit protein stability and function at the cell surface. Understanding this process in more detail will provide a broader base of knowledge of how pharmacological chaperones and different classes of compounds can be used to promote protein function and stability of this and other TS mutations.
